Peel away hemostasis valve

Information

  • Patent Grant
  • 11045634
  • Patent Number
    11,045,634
  • Date Filed
    Tuesday, November 6, 2018
    5 years ago
  • Date Issued
    Tuesday, June 29, 2021
    2 years ago
Abstract
A hemostasis valve body provides strong sealing around a medical device during insertion of the medical device into a blood vessel, low forces for tearing, and stability during insertion of the medical devices as well as during peel away. The valve body comprises a first surface, a second surface opposite the first surface, an edge, helical slits, and a pair of longitudinal cuts. The helical slits are positioned at a center of the valve body and traverse the first surface to the second surface. The helical slits provide a seal around the medical device. Each respective longitudinal cut extends from the first surface partially through the valve body to a depth short of the second surface for at least part of a length of the respective longitudinal cut. The longitudinal cuts facilitate a separation of the valve body into two parts during a peel away action.
Description
FIELD OF THE INVENTION

The present disclosure relates to systems and methods for implementing a peel away hemostasis valve.


BACKGROUND

An introducer sheath is used for the percutaneous insertion of medical devices such as heart pumps, guidewires, and diagnostic catheters into an artery or vein of a patient. A hemostasis valve and a hub are parts of the introducer sheath that are designed to have medical devices inserted through and be able to be removed in-line from the inserted medical devices. During the insertion of the medical devices, hemostasis valves should resist tearing while maintaining hemostasis. In addition, the hemostasis valve may split into two pieces with acceptable force during a peel away action of the introducer sheath.


Some peel away hemostasis valve designs have a thickness that helps with sealing but requires high force to tear. Other peel away hemostasis valve designs are cut all the way through the thickness of the valve body to provide low forces for tearing but have trouble sealing around the medical devices used throughout the procedure. However, many current peel away hemostasis valves do not exhibit the performance necessary for the insertion of modern heart pump systems.


In addition to sealing performance and ease of peel away, hemostasis valves should also allow for stability during insertion of heart pump systems as well as during peel away. Some peel away hemostasis valve designs suffer from a double break during peel away, which occurs when the valve has two distinct points of resistance to tearing. For example, the double break points may be located near the edge of the valve and at the center of the valve. A double break causes movement of the heart pump system while in the artery or vein of the patient and can cause damage to the arteriotomy of the patient and/or damage to the heart pump system. There is a need for a hemostasis valve design that mitigates double breaks during peel away and improves the stability of the heart pump system placement during a procedure.


SUMMARY OF INVENTION

The systems, methods, and devices described herein provide for a peel away hemostasis valve designed in a manner to provide low forces for tearing, strong sealing around the medical devices, and stability during insertion of the medical devices as well as during peel away. The valve of the present disclosure has longitudinal cuts that are defined by a cylindrical surface axially aligned with the outer diameter of the hemostasis valve and an edge that aligns with the spiral path of one of the helical slits at the center of the hemostasis valve. Compared with existing valves, the design of the longitudinal cuts in the valve of the present disclosure reduces the required force to tear through the peel away hemostasis valve during a peel away action. The longitudinal cuts and the helical slits are separated by a constant distance through the thickness of the valve, which provides better hemostasis performance compared to a hemostasis valve that has longitudinal cuts all the way through the valve. The peel away hemostasis valve of the present disclosure also has through holes along its perimeter that facilitate connection of the hemostasis valve to the hub of an introducer and maintains a stretch (when posts are inserted in the through holes) in the hemostasis valve during a peel away action.


Embodiments are disclosed herein for a hemostasis valve body comprising a first surface, a second surface opposite the first surface, an edge, helical slits, and a pair of longitudinal cuts. The edge extends between the outer perimeters of the first surface and the second surface. The helical slits are positioned at a center of the valve body and traverse the first surface to the second surface. The helical slits provide a seal around a medical device during an insertion of the medical device into a blood vessel. Each respective longitudinal cut extends from the first surface partially through the valve body to a depth short of the second surface for at least part of a length of the respective longitudinal cut. The longitudinal cuts facilitate a separation of the valve body into two parts during a peel away action. The embodiments disclosed herein provide a peel away hemostasis valve that seals well to a medical device inserted therein and also allows for peeling away the hemostasis valve with low force. Additionally, the design of the peel away hemostasis valve prevents a double break and facilitates stability of medical devices or heart pump systems during procedures.


In certain implementations, the longitudinal cuts may be positioned at a distance from the helical slits. According to some implementations, the longitudinal cuts may be angled at a similar angle of rotation as the helical slits. In certain implementations, each respective longitudinal cut may be positioned on opposite sides of the valve body. According to some implementations, each respective longitudinal cut may traverse the first surface to the second surface for at least part of the length of the respective longitudinal cut near the edge.


According to one implementation, the hemostasis valve body may comprise a first group of lines formed on the first surface and a second group of lines formed on the second surface. The first group of lines may extend radially outward from the center of the valve. The second group of lines may extend radially outward from the center of the valve. In some implementations, the helical slits may traverse the first group of lines to the second group of lines. According to some implementations, the first group of lines may be angularly offset from the second group of lines.


In certain implementations, the hemostasis valve body may comprise through holes at a distance from the edge that traverse the first surface to the second surface. According to some implementations, each respective through hole may comprise one of round edges, flat edges, and non-symmetric shape. In some implementations, the through holes may be angularly spaced equally. According to certain implementations, the angle between adjacent through holes may be less than or equal to 25 degrees. In other implementations, the through holes may be sized to accommodate ports. According to some implementations, the through holes (when posts are inserted therethrough) may keep the hemostasis valve body stretched during a peel away action.


According to one implementation, the first surface may be parallel to the second surface. In some implementations, the first surface and the second surface may comprise a planar shape. According to some implementations, the first surface may comprise one of a conical, tapered, and convex shape. In certain implementations, a shallow point of the first surface may be at the center of the valve.


According to some implementations, the valve body may comprise a disc shape. According to one implementation, the valve body may comprise one of a cylindrical and cubic shape.


According to a further implementation of the present disclosure, a system is provided for inserting a blood pump into a blood vessel of a patient. The system includes a blood pump and an introducer assembly, which comprises a sheath and a hub that includes the hemostasis valve body. The sheath and the hemostasis valve body can be sized to receive the blood pump. The introducer hub includes wings and notches that facilitate the breaking of the introducer hub. A medical service professional applies force on the wings in order to break the introducer hub during a peel away action. The notches are purposefully implemented as weak points on the hub that break when sufficient force is applied on the wings. The longitudinal cuts on the hemostasis valve body can be radially aligned with the notches in order for the valve to break without much force along the longitudinal cuts.


According to a further implementation of the present disclosure, a method is provided for peeling away an introducer sheath assembly having (1) an introducer hub, the introducer hub having (a) first and second wings located opposite each other, and (b) first and second notches located at midpoints between the first and second wings, (2) a hemostasis valve within the introducer hub having first and second longitudinal cuts radially aligned with the first and second notches, and (3) a introducer sheath having longitudinal scoring aligned with the first and second notches. As described above, the wings and notches facilitate the breaking of the introducer hub. Compared with other peel away methods, this method achieves a smooth peel away along a consistent tearing path by aligning purposefully implemented weak points on the introducer hub, hemostasis valve, and introducer sheath. The method comprises applying a first force to the first wing of the introducer hub in a first direction radial from an introducer sheath and a second force to the second wing of the introducer hub in a second direction opposite the first direction. The method further comprises causing the first force and the second force to be transmitted to the first and second notches of the introducer hub, thereby breaking the first and second notches. The method further comprises causing the hemostasis valve to break along the first and second longitudinal cuts. The method further comprises separating the introducer sheath along the longitudinal scoring.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and other objects and advantages will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:



FIG. 1 shows an illustrative medical device, configured according to one or more aspects of the present disclosure;



FIG. 2 shows an illustrative introducer inserted into a blood vessel of a patient with the medical device of FIG. 1 extending therethrough, configured according to one or more aspects of the present disclosure;



FIG. 3 shows a cross-section of the medical device of FIG. 1 inserted into a peel away hemostasis valve of the introducer of FIG. 2, configured according to one or more aspects of the present disclosure;



FIG. 4 shows an isometric view of a peel away hemostasis valve, configured according to one or more aspects of the present disclosure;



FIG. 5 shows an isometric view of a peel away hemostasis valve with hidden lines, configured according to one or more aspects of the present disclosure;



FIG. 6 shows a bottom view of a peel away hemostasis valve, configured according to one or more aspects of the present disclosure;



FIG. 7 shows a top view of a peel away hemostasis valve, configured according to one or more aspects of the present disclosure;



FIG. 8 shows a side view of a peel away hemostasis valve, configured according to one or more aspects of the present disclosure;



FIG. 9 shows a top view of an introducer hub, configured according to one or more aspects of the present disclosure;



FIG. 10 shows an isometric view of an introducer hub, configured according to one or more aspects of the present disclosure;



FIG. 11 shows a top view of a peel away hemostasis valve inserted into an introducer hub, configured according to one or more aspects of the present disclosure;



FIG. 12 shows an isometric view of a peel away hemostasis valve inserted into an introducer hub, configured according to one or more aspects of the present disclosure; and



FIG. 13 shows a flowchart for peeling away an introducer having a peel away hemostasis valve, configured according to one or more aspects of the present disclosure.





DETAILED DESCRIPTION

There is a need for a peel away hemostasis valve that seals well and has features allowing for peeling away the hemostasis valve with low force. The peel away hemostasis valve described herein accomplishes this by incorporating longitudinal cuts that are defined by a cylindrical surface axially aligned with the outer diameter of the hemostasis valve and an edge that aligns with the spiral path of one of the helical slits at the center of the hemostasis valve. The design of the longitudinal cuts lowers the required force to tear through the peel away hemostasis valve during a peel away action. The longitudinal cuts and the helical slits are separated by a constant distance which provides better hemostasis performance compared to a hemostasis valve that is cut all the way through. Additionally, there is a need for a peel away hemostasis valve that does not double break and facilitates stability of heart pump systems during procedures. The peel away hemostasis valve described herein accomplishes this by incorporating through holes along the perimeter of the hemostasis valve that connect the hemostasis valve to the hub of an introducer and keeps the hemostasis valve stretched (when posts are inserted through the through holes) during a peel away.



FIG. 1 shows an illustrative medical device such as a blood pump 100 according to certain implementations. The blood pump 100 may be an intravascular heart pump, a heart pump driven by a flexible shaft and a motor positioned external to the patient's body, a heart pump including an implantable motor, a heart pump having an expandable pump rotor, or any other suitable pump. The blood pump 100 comprises a pump handle 110, a pump head 130, a catheter 120 connecting the pump handle 110 to the pump head 130, and a connecting hub 160. The catheter 120 is tubular and has a substantially uniform outer diameter 150. The catheter 120 enables the pump head 130 and the pump handle 110 to be in electro-mechanical communication. The pump handle 110 is in communication with control circuitry which allows the control of the pump head 130. The pump head 130 contains electro-mechanical components that enable the device to perform various tasks within the body of a patient, such as pump blood from a location within the body. The pump head 130 has a diameter 140 that is larger than the diameter 150 of the catheter 120. An example of such a percutaneous pump is the Impella 2.5® system (Abiomed, Inc., Danvers, Mass.).


As depicted in FIG. 2, the blood pump 100 is inserted into a blood vessel 240 of a patient using an introducer 200. The introducer 200 includes a hub 210 and an elongate sheath 202. The hub 210 includes hemostasis valve 300 (described further below) which provides a seal and minimizes fluid loss during the insertion of the blood pump 100. The elongate sheath 202 is sized for insertion into the blood vessel 240 of a patient. The introducer 200 is advanced into the blood vessel 240 through a blood vessel aperture 250 in the direction indicated by arrow 248 and then the blood pump 100 is inserted through the hub 210 and elongate sheath 202, and into the blood vessel 240. The blood vessel 240 may be a femoral artery, and the blood vessel aperture 250 may be an arteriotomy.


After the blood pump 100 has been advanced through the introducer 200, the introducer 200 may be removed and, in some implementations, replaced by a device appropriate for longer-term use. To remove the introducer 200, a healthcare professional may grasp first and second wings 218a and 218b of the hub 210, and apply a force to the wings 218a and 218b in a direction either toward the elongate sheath 202 or a direction radial to the elongate sheath 202, forcing the first wing 218a toward the second wing 218b depending on the orientations of the first and second wings 218a and 218b relative to the elongate sheath 202. In the orientation of wings 218a and 218b as shown in FIG. 2, the healthcare professional applies a radial force (radial with respect to the elongate sheath 202) to the wings 218a and 218b to move them toward each other. The first and second wings 218a and 218b are formed of a stiff material and do not flex when force is applied. Instead, the applied force is transmitted from the wings 218a and 218b to a first notch 214 and second notch (not shown) on the introducer hub 210. The second notch is located opposite the first notch 214, and both of the first notch 214 and second notch are located at a midpoint between the first and second wings 218a and 218b. The minimum thicknesses at the notches allows the introducer 200 to break at the first notch 214 and second notch. The longitudinal scoring 222 on the elongate sheath 202 allows the sheath to separate along the length of the elongate sheath, and the hub 210 and elongate sheath 202 may be peeled away in two pieces leaving the percutaneous pump 100 in place in the blood vessel 240.



FIG. 3 shows a cross-section of the blood pump 100 of FIG. 1 inserted into the introducer 200 of FIG. 2. The hub 210 of introducer 200 includes hemostasis valve 300 that provides a seal and minimizes fluid loss during the insertion of the blood pump 100. The hemostasis valve 300 described in FIGS. 4-8 seals well and has features allowing for peeling away the peel away hemostasis valve with low force as described below.



FIG. 4 shows an isometric view of a peel away hemostasis valve 300. Peel away hemostasis valve 300 includes first surface 302, second surface 304 that is opposite and parallel to the first surface 302, and edge 306 that extends between the outer perimeters of the first surface 302 and the second surface 304.


As depicted in FIG. 4, peel away hemostasis valve 300 has a disc shape, in which the first surface 302 and the second surface 304 are planar and circular, and the edge 306 extends perpendicularly from each of the first and second surfaces 302 and 304. In general, the peel away hemostasis valve 300 may take on other shapes, including but not limited to cylindrical or cubic shape. A disc shape may be a subset of a cylinder whereby the ratio of the thickness of edge 306 to the diameter of the first surface 302 is less than 1. In general, the shapes of the first surface 302 and the second surface 304 may be any suitable shape, such as a triangle, square, pentagon, hexagon, or any other polygon. While the first surface 302 and the second surface 304 are depicted in FIG. 4 as being planar surfaces, the surfaces 302 and 304 may include any combination of conical, tapered, convex, concave, or planar. In particular, the thickness of the valve 308 (i.e., the distance between respective points on the surfaces 302 and 304) may vary throughout the valve body. For example, the valve may be thinnest at its center, such that one or both of surfaces 302 and 304 may include a shallow point at its center.


The thickness 308 of the peel away hemostasis valve 300 may be set to achieve the specific hemostasis performance required. The hemostasis performance of the peel away hemostasis valve is improved if the thickness 308 of the peel away hemostasis valve 300 is set to a large value. In another aspect, the thickness 308 of the peel away hemostasis valve 300 may be set to require a certain amount of force during a peel away action. The amount of force required during a peel away action is small if the thickness 308 of the peel away hemostasis valve 300 is set to a small value. In some aspects, the thickness 308 of the peel away hemostasis valve 300 may be set to satisfy a tradeoff between the specific hemostasis performance and the required amount of force during a peel away action.


Peel away hemostasis valve 300 may be inserted into the vasculature by an introducer sheath. Peel away hemostasis valve 300 may have medical devices inserted through and may be able to be removed in-line from the inserted medical devices. The medical devices may include heart pumps, guidewires, diagnostic catheters, sheaths, and dilators.



FIG. 5 shows an isometric view of a peel away hemostasis valve 300 with hidden dotted lines, which depict cuts present in the valve. FIG. 6 shows a bottom view of the peel away hemostasis valve 300. Peel away hemostasis valve 300 includes through holes 312 positioned along the periphery of the valve, first group of lines 314 at the center of the valve at the top surface, second group of lines 324 at the center of the valve at the bottom surface, helical slits 316 extending through the center of the valve, longitudinal cuts 318a and 318b positioned on opposite sides of the valve and extending away from each other, and through slits 322a and 322b.


As depicted in FIGS. 5 and 6, the first group of lines 314 are formed on first surface 302, include three diameter cuts with the same center, and extend radially outward from the center of peel away hemostasis valve 300. A second group of lines 324 are formed on second surface 304 and have the same shape as the first group of lines 314. The first group of lines 314 and the second group of lines 324 have a snowflake shape. The snowflake shape may have four-fold radial symmetry, six-fold radial symmetry, eight-fold radial symmetry, or any other suitable radial symmetry. The angular offset between the lines in the snowflake shape may be 90°, 60°, 45°, 30°, or any other suitable angle. In another aspect, the snowflake shape may not have radial symmetry.


Helical slits 316 traverse through the center of the valve from the first group of lines 314 in the first surface 302 to the second group of lines 324 in the second surface 304. The helical slits 316 follow a spiral path between first surface 302 and second surface 304. The length of the first group of lines 314 and the second group of lines 324 determines the size of the helical slits 316. The size of the helical slits 316 may be set to balance the hemostasis performance with the insertion and removal force of the medical devices inserted through the peel away hemostasis valve 300. As the length of the first group of lines 314 and the second group of lines 324 increases, the size of the helical slits 316 increases, the hemostasis performance of the peel away hemostasis valve 300 decreases, and the removal force of the medical devices inserted through the peel away hemostasis valve 300 decreases.


Each longitudinal cut 318a and 318b may extend from first surface 302 partially through the peel away hemostasis valve 300 to a depth short of second surface 304 for at least part of a length of the respective longitudinal cut 318a or 318b.


Longitudinal cuts 318a and 318b facilitate a separation of the peel away hemostasis valve 300 into two parts during a peel away action. Longitudinal cuts 318a and 318b may be positioned at a distance from helical slits 316. Each longitudinal cut 318a and 318b may be positioned on opposite sides of the peel away hemostasis valve 300. Each longitudinal cut 318a and 318b may traverse first surface 302 to second surface 304 for at least part of the length of the respective longitudinal cut 318a or 318b near edge 306. The region where the longitudinal cut 318a or 318b traverses through the entire thickness 308 of the hemostasis valve 300 is referred to herein as a through slit 322a or 322b, which may serve as an origin for tear propagation during a peel away action. The termination of the longitudinal cuts 318a and 318b at the first surface 302 of the peel away hemostasis valve 300 may be a sharp edge.


In some embodiments, longitudinal cuts 318a and 318b are angled at a similar angle of rotation as the helical slits 316. As depicted in FIG. 7, the angle α of the helical slits 316 defines an angular path the helix slits 316 go through as they traverse the valve 300 from the first surface 302 to the second surface 304. In general, α can be any angle that matches the angular offset between the first group of lines 314 on the first surface 302 and the second group of lines 324 on the second surface 304. In another aspect, the angle α matches the angular offset of two of the helical slits 316 on the first surface 302. In some aspects, α is equal to 360/n, where n is a number of helical slits 316. In another aspect, α is not related to the angular offset of two of the lines 314 on the first surface 302. In this case, α is the angle of rotation of the helix between the first and second surfaces 302 and 304, and need not correspond to an angle between two lines 314, such that the first group of lines 314 and the second group of lines 324 may be angularly offset from each other. As depicted in FIG. 8, the angle β of the longitudinal cuts 318a and 318b defines the angle between the two faces of each longitudinal cut 318a and 318b. The angles α and β may be related to each other. In some aspects, α and β are within 5%, 10%, or 15% of each other, or any other suitable percentage. In another aspect, α and β are proportional to each other. By aligning longitudinal cuts 318a and 318b with helical slits 316 (i.e., by ensuring that α and β are such that the face of the longitudinal cuts 318a and 318b nearest to the corresponding cut in the helical slit 316 follows the path of the corresponding cut in the helical slit 316), a constant distance is maintained between the longitudinal cut 318 and the nearest corresponding cut in the helical slit 316. The constant distance between longitudinal cuts 318a and 318b and helical slits 316 may be set appropriately to fine tune the amount of force required during a peel away action. If the constant distance between longitudinal cuts 318a and 318b and helical slits 316 is set to a high value, a larger force is required during a peel away action.


During a peel away action, a tear starts at the through slits 322a and 322b (located near the edge 306 of the valve) and propagates along the portion of the longitudinal cuts 318a and 318b near the second surface 304. The tear then proceeds to propagates from the second surface 304 to the first surface 302 along the distance between the longitudinal cuts 318a and 318b and the helical slits 166. The tear propagation results in splitting the peel away hemostasis valve 300 into two pieces along the path described.


In certain implementations, peel away hemostasis valve 300 is partially surrounded by the hub 210 of introducer 200 (as described further in relation to FIGS. 11 and 12) and aligned with notches on the hub 210, such that the longitudinal cuts 318a and 318b of peel away hemostasis valve 300 are aligned with the notches. By aligning the longitudinal cuts 318a and 318b with the notches, the user can use a low force to easily split the peel away hemostasis valve 300 into two pieces during a peel away action using the introducer assembly 200.



FIGS. 9 and 10 show top and isometric views, respectively, of the hub 210 of introducer 200. As shown, hub 210 has posts 260 arranged in a circle around its perimeter and with equal angular spacing between them except for the spacing between the posts 260 nearest to the notches of the hub 210. The angular spacing between the posts 260 nearest to the notches of the hub 210 is larger than the spacing between the other posts 260 because the hub 210 breaks along the notches. The posts 260 in hub 210 extend through the through holes 312 on the valve, such that the posts 260 facilitate anchoring and secure the valve 300 within the hub 210. The through holes 312 are located at a distance from the valve's edge 306 and traverse the first surface 302 to the second surface 304. While the through holes 312 depicted in FIGS. 4-7 are circular, each through hole 312 may include round edges, flat edges, or a non-symmetric shape. FIGS. 11 and 12 show top and isometric views, respectively, of the valve 300 inserted into the hub 210. As shown, the through holes 312 are angularly aligned with posts 260 but are slightly axially offset. In particular, the posts 260 have a centerline diameter that is slightly less than the centerline diameter of the through holes 312. This offset provides improved sealing pressure inward on the valve 300, by ensuring that the valve remains in a stretched state while within the hub. In some embodiments, the posts 260 have a centerline diameter that is the same as the through holes 312 centerline diameter.


The design depicted in FIGS. 11 and 12 ensure that during a peel away action, the valve 300 is stretched, thereby allowing for a smooth break of the hemostasis valve 300 and preventing a double break. This is achieved by angularly spacing the through holes 312 equally except for the spacing between the posts 260 nearest to the notches of the hub 210. In some embodiments the angular spacing is less than or equal to 25 degrees. The ideal angular spacing of through holes 312 for a hemostasis valve 300 with an outer diameter greater than or equal to 15 mm and through hole 312 diameter greater than or equal to 0.75 mm is less than or equal to 25 degrees with spacing between through holes 312 being equal.



FIG. 13 shows a process 1300 for peeling away an introducer 200 having (1) an introducer hub 210 having (a) first and second wings 218a and 218b located opposite each other, and (b) first and second notches 214 located at midpoints between the first and second wings 218a and 218b, (2) a a peel away hemostasis valve 300 within the introducer hub 210, having first and second longitudinal cuts 318a and 318b radially aligned with the first and second notches 214, and (3) an introducer sheath 202 having longitudinal scoring 222 aligned with the first and second notches 214. Process 1300 may be used by a medical health professional after insertion of a medical device through introducer 200. At step 1302, a first force is applied to a first wing 218a of the introducer hub 210 in a first direction radial from the introducer sheath 202 and a second force is applied to the second wing 218b of the introducer hub 210 in a second direction opposite the first direction. For example, the healthcare professional may grasp first and second wings 218a and 218b of the hub 210, and apply a force to the wings 218a and 218b in a direction either toward the elongate sheath 202 or a direction radially extending away from the elongate sheath 202, forcing the first wing 218a toward the second wing 218b depending on the orientations of the first and second wings 218a and 218b relative to the elongate sheath 202.


At step 1304, the first force and the second force are transmitted to the first notch 214 and the second notch of the introducer hub 210, causing the first and second notches 214 to break. For example, the applied force is transmitted from the wings 218a and 218b to a first notch 214 and second notch. The minimum thicknesses at the notches allows the introducer hub 210 to break at the first notch 214 and second notch. Additionally, the shape of the notches concentrate stress to facilitate splitting of the hub 210 along the notches. The minimum thickness and shape of the notches provide a break wall at which a crack may be initiated in the hub 210. In some implementations, the minimum thickness of the notches ranges from 0.075 mm to 0.35 mm.


At step 1306, the hemostasis valve 300 of the introducer hub 210 is broken along the first longitudinal cut 318a and the second longitudinal cut 318b. The first longitudinal cut 318a is aligned with the first notch 214 and the second longitudinal cut 318b is aligned with the second notch For example, a tear starts at the through slits 322a and 322b, located near the edge 306 of the valve and at the radial ends of the longitudinal cuts 318a and 318b, respectively. The tear then propagates radially inward along the portion of the longitudinal cuts 318a and 318b near the second surface 304. This results in the longitudinal cuts 318a and 318b being completely cut through the thickness of the valve. At this point, the valve 300 is still intact at the region between the longitudinal cuts and the helical slits. The tear then proceeds to propagate through this region between the longitudinal cuts 318a and 318b and the helical slits 166. The tear propagation in this region can occur in a radial direction, in a direction through the thickness of the valve 300, or in a vector having components in both directions. The tear propagation in this region results in splitting the peel away hemostasis valve 300 into two pieces along the path described.


At step 1308, the introducer sheath 202 is separated along longitudinal scoring 222 on the introducer sheath 202. The longitudinal scoring 222 is radially aligned with the first notch 214 and the second notch. For example, the longitudinal scoring 222 on the elongate sheath 202 allows the sheath to separate along the length of the elongate sheath 202, and the hub 210 and elongate sheath 202 is peeled away in two pieces. After the introducer is peeled away, the percutaneous pump 100 is left in place in the blood vessel 240.


Other objects, advantages and aspects of the various aspects of the present invention will be apparent to those who are skilled in the field of the invention and are within the scope of the description and the accompanying Figures. For example, but without limitation, structural or functional elements might be rearranged. Similarly, principles according to the present invention could be applied to other examples, which, even if not specifically described here in detail, would nevertheless be within the scope of the present invention.

Claims
  • 1. A hemostasis valve body, comprising: a first surface and a second surface opposite the first surface;an edge extending between an outer perimeter of the first surface and an outer perimeter of the second surface;a plurality of helical slits at a center of the hemostasis valve body that traverse the first surface to the second surface, wherein the helical slits provide a seal around a medical device during an insertion of the medical device into a blood vessel; anda pair of longitudinal cuts, each longitudinal cut extending from the first surface partially through the hemostasis valve body to a depth short of the second surface for a portion of a length of the respective longitudinal cut or for an entire length of the respective longitudinal cut, wherein the pair of longitudinal cuts facilitates a separation of the hemostasis valve body into two parts during a peel away action, andwherein each longitudinal cut is spaced from the helical slits such that an interior edge of each longitudinal cut is at a constant distance from a helical slit closest to the interior edge of the longitudinal cut, and wherein the constant distance is maintained through a thickness of the hemostasis valve body extending from the first surface to the second surface.
  • 2. The hemostasis valve body of claim 1, wherein the pair of longitudinal cuts are angled at an angle of rotation that is same as an angle of rotation of the helical slits.
  • 3. The hemostasis valve body of claim 1, wherein each longitudinal cut is positioned on diametrically opposite sides of the hemostasis valve body.
  • 4. The hemostasis valve body of claim 1, wherein each longitudinal cut traverses the first surface to the second surface for a portion of the length of the respective longitudinal cut or for an entire length of the respective longitudinal cut at the edge.
  • 5. The hemostasis valve body of claim 1, further comprising: a first group of lines formed on the first surface, wherein the first group of lines extend radially outward from the center of the hemostasis valve body; anda second group of lines formed on the second surface, wherein the second group of lines extend radially outward from the center of the hemostasis valve body.
  • 6. The hemostasis valve body of claim 5, wherein the plurality of helical slits traverse the first group of lines to the second group of lines.
  • 7. The hemostasis valve body of claim 5, wherein the first group of lines are angularly offset from the second group of lines.
  • 8. The hemostasis valve body of claim 1, further comprising a plurality of through holes at a distance from the edge that traverse the first surface to the second surface.
  • 9. The hemostasis valve body of claim 8, wherein each through hole comprises one of round edges, flat edges, and non-symmetric shape.
  • 10. The hemostasis valve body of claim 8, wherein at least some of the plurality of through holes are angularly spaced equally.
  • 11. The hemostasis valve body of claim 10, wherein an angle between adjacent through holes is less than or equal to 25 degrees.
  • 12. The hemostasis valve body of claim 8, wherein the plurality of through holes are sized to accommodate a plurality of posts of an introducer hub.
  • 13. The hemostasis valve body of claim 8, wherein a plurality of posts of an introducer hub are configured to be inserted into the plurality of through holes.
  • 14. The hemostasis valve body of claim 13, wherein the plurality of posts of the introducer hub when inserted into the plurality of through holes keep the hemostasis valve body stretched during a peel away action.
  • 15. The hemostasis valve body of claim 1, wherein the first surface is parallel to the second surface.
  • 16. The hemostasis valve body of claim 1, wherein the first surface and the second surface comprises a planar shape.
  • 17. The hemostasis valve body of claim 1, wherein the first surface comprises one of a conical, tapered, and convex shape.
  • 18. The hemostasis valve body of claim 1, wherein a thickness of the hemostasis valve body is minimum at the center of the hemostasis valve body.
  • 19. The hemostasis valve body of claim 1, wherein the hemostasis valve body comprises one of a disc, cylindrical, and cubic shape.
  • 20. A system for inserting a blood pump into a blood vessel of a patient comprising: a blood pump; andan introducer assembly comprising a hub and a sheath,wherein the hub comprises: a first wing and a second wing located opposite each other;a first notch and a second notch located at mid points between the first wing and the second wing; anda hemostasis valve body, wherein the hemostasis valve body comprises: a first surface and a second surface opposite the first surface;an edge extending between an outer perimeter of the first surface and an outer perimeter of the second surface;a plurality of helical slits at a center of the hemostasis valve body that traverse the first surface to the second surface, wherein the helical slits provide a seal around the blood pump during an insertion of the blood pump into a blood vessel;a first longitudinal cut; anda second longitudinal cut,wherein each of the first longitudinal cut and the second longitudinal cut is spaced apart from the helical slits,wherein the first longitudinal cut extends from the first surface partially through the hemostasis valve body to a depth short of the second surface for a portion of a length of the first longitudinal cut or for an entire length of the first longitudinal cut,wherein the second longitudinal cut extends from the first surface partially through the hemostasis valve body to a depth short of the second surface for a portion of a length of the second longitudinal cut or for an entire length of the second longitudinal cut,wherein the first longitudinal cut is radially aligned with the first notch and the second longitudinal cut is radially aligned with the second notch,wherein the first longitudinal cut and the second longitudinal cut facilitate a separation of the hemostasis valve body into two parts during a peel away action, andwherein the hemostasis valve body and the sheath are sized to receive the blood pump.
  • 21. A system for inserting a blood pump into a blood vessel of a patient comprising: a blood pump; andan introducer assembly comprising a hub and a sheath,wherein the hub comprises: a first wing and a second wing located opposite each other;a first notch and a second notch located at mid points between the first wing and the second wing; anda hemostasis valve body,wherein the hemostasis valve body comprises: a first surface and a second surface opposite the first surface;an edge extending between an outer perimeter of the first surface and an outer perimeter of the second surface;a plurality of helical slits at a center of the hemostasis valve body that traverse the first surface to the second surface, wherein the helical slits provide a seal around the blood pump during an insertion of the blood pump into a blood vessel;a first longitudinal cut;a second longitudinal cut;wherein each of the first longitudinal cut and the second longitudinal cut is spaced apart from the helical slits, wherein the first longitudinal cut extends from the first surface partially through the hemostasis valve body to a depth short of the second surface for a portion of a length of the first longitudinal cut or for an entire length of the first longitudinal cut,wherein the second longitudinal cut extends from the first surface partially through the hemostasis valve body to a depth short of the second surface for a portion of a length of the second longitudinal cut or for an entire length of the second longitudinal cut,wherein the first longitudinal cut is radially aligned with the first notch and the second longitudinal cut is radially aligned with the second notch,wherein the first longitudinal cut and the second longitudinal cut facilitate a separation of the hemostasis valve body into two parts during a peel away action; anda plurality of through holes at a distance from the edge that traverse the first surface to the second surface,wherein the hemostasis valve body and the sheath are sized to receive the blood pump, andwherein the hub comprises a plurality of posts that are configured to be inserted into the plurality of through holes of the hemostasis valve body during operation of the blood pump.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims the benefit of U.S. Provisional Application No. 62/582,075, filed on Nov. 6, 2017, the content of which is hereby incorporated herein by reference in its entirety.

US Referenced Citations (220)
Number Name Date Kind
4317445 Robinson Mar 1982 A
4380252 Gray et al. Apr 1983 A
4402685 Buhler et al. Sep 1983 A
4569347 Frisbie Feb 1986 A
4651751 Swendson et al. Mar 1987 A
4699611 Bowden Oct 1987 A
4798594 Hillstead Jan 1989 A
4895346 Steigerwald Jan 1990 A
4895565 Hillstead Jan 1990 A
5041095 Littrell Aug 1991 A
5069674 Fearnot et al. Dec 1991 A
5114408 Fleischhaker May 1992 A
5139486 Moss Aug 1992 A
5180372 Vegoe et al. Jan 1993 A
5221255 Mahurkar et al. Jun 1993 A
5234425 Fogarty et al. Aug 1993 A
5279596 Castaneda et al. Jan 1994 A
5304142 Liebl et al. Apr 1994 A
5312355 Lee May 1994 A
5320611 Bonutti et al. Jun 1994 A
5350363 Goode Sep 1994 A
5380304 Parker Jan 1995 A
5395341 Slater Mar 1995 A
5397310 Chu et al. Mar 1995 A
5397311 Walker et al. Mar 1995 A
5405338 Kranys Apr 1995 A
5407430 Peters Apr 1995 A
5409463 Thomas et al. Apr 1995 A
5409469 Schaerf Apr 1995 A
5488960 Toner Feb 1996 A
5492530 Fischell et al. Feb 1996 A
5520655 Davila May 1996 A
5536255 Moss Jul 1996 A
5573517 Bonutti et al. Nov 1996 A
5599326 Carter Feb 1997 A
5653697 Quiachon et al. Aug 1997 A
5713867 Morris Feb 1998 A
5752937 Otten et al. May 1998 A
5795341 Samson Aug 1998 A
5827242 Follmer et al. Oct 1998 A
5911702 Romley et al. Jun 1999 A
5935122 Fourkas et al. Aug 1999 A
5971993 Hussein et al. Oct 1999 A
6042578 Dinh et al. Mar 2000 A
6068622 Sater et al. May 2000 A
6165163 Chien et al. Dec 2000 A
6197014 Samson et al. Mar 2001 B1
6197016 Fourkas et al. Mar 2001 B1
6217565 Cohen Apr 2001 B1
6258080 Samson Jul 2001 B1
6290692 Klima et al. Sep 2001 B1
6338730 Bonutti et al. Jan 2002 B1
6363273 Mastrorio et al. Mar 2002 B1
6379346 McIvor et al. Apr 2002 B1
6423052 Escano Jul 2002 B1
6428556 Chin Aug 2002 B1
6508966 Castro et al. Jan 2003 B1
6544270 Zhang Apr 2003 B1
6562049 Norlander et al. May 2003 B1
6589227 Sønderskov Klint Jul 2003 B2
6613038 Bonutti et al. Sep 2003 B2
6692462 Mackenzie et al. Feb 2004 B2
6702972 Markle Mar 2004 B1
6740073 Saville May 2004 B1
6749600 Levy Jun 2004 B1
6814715 Bonutti et al. Nov 2004 B2
6824553 Samson et al. Nov 2004 B1
6827710 Mooney et al. Dec 2004 B1
6852261 Benjamin Feb 2005 B2
6866660 Garabedian et al. Mar 2005 B2
6881211 Schweikert et al. Apr 2005 B2
6939327 Hall et al. Sep 2005 B2
6939337 Parker et al. Sep 2005 B2
7018372 Casey et al. Mar 2006 B2
7025746 Tal Apr 2006 B2
7037295 Tiernan et al. May 2006 B2
7101353 Lui et al. Sep 2006 B2
7144411 Ginn et al. Dec 2006 B2
7226433 Bonnette et al. Jun 2007 B2
7438712 Chouinard Oct 2008 B2
7497844 Spear et al. Mar 2009 B2
7524305 Moyer Apr 2009 B2
7540865 Griffin et al. Jun 2009 B2
7628769 Grandt et al. Dec 2009 B2
7645273 Lualdi Jan 2010 B2
7704245 Dittman et al. Apr 2010 B2
7713260 Lessard et al. May 2010 B2
7722567 Tal May 2010 B2
7731694 Becker et al. Jun 2010 B2
7744571 Fisher et al. Jun 2010 B2
7749185 Wilson et al. Jul 2010 B2
7766820 Core Aug 2010 B2
7833218 Lunn et al. Nov 2010 B2
7837671 Eversull et al. Nov 2010 B2
7871398 Chesnin et al. Jan 2011 B2
7905877 Jimenez et al. Mar 2011 B1
7963948 Melsheimer Jun 2011 B2
7968038 Dittman et al. Jun 2011 B2
7985213 Parker Jul 2011 B2
7993305 Ye et al. Aug 2011 B2
8123726 Searfoss et al. Feb 2012 B2
8206375 Snow Jun 2012 B2
8246574 Jacobs et al. Aug 2012 B2
8257298 Hamboly Sep 2012 B2
8273059 Nardeo et al. Sep 2012 B2
8298189 Fisher et al. Oct 2012 B2
8317754 Leeflang et al. Nov 2012 B2
8343136 Howat et al. Jan 2013 B2
8377035 Zhou et al. Feb 2013 B2
8398696 Buiser et al. Mar 2013 B2
8597277 Lenker et al. Dec 2013 B2
8636270 Ostrovsky Jan 2014 B2
8672888 Tal Mar 2014 B2
8684963 Qiu et al. Apr 2014 B2
8728055 Stehr et al. May 2014 B2
8758402 Jenson et al. Jun 2014 B2
8821510 Parker Sep 2014 B2
8974420 Searfoss et al. Mar 2015 B2
9168359 Rowe et al. Oct 2015 B2
9295809 Sheetz Mar 2016 B2
9320873 Okamura Apr 2016 B2
9352116 Guo et al. May 2016 B2
9427551 Leeflang et al. Aug 2016 B2
9492636 Heideman et al. Nov 2016 B2
9539368 Haslinger et al. Jan 2017 B2
9539411 Cully et al. Jan 2017 B2
9545496 Hiroshige et al. Jan 2017 B2
9597481 Ishikawa Mar 2017 B2
9622892 Baker et al. Apr 2017 B2
9629978 Eversull et al. Apr 2017 B2
9707373 Nielsen Jul 2017 B2
9901706 Storbeck et al. Feb 2018 B2
9937319 Leeflang et al. Apr 2018 B1
9980710 Seifert et al. May 2018 B2
9981115 Merk et al. May 2018 B2
9987460 Brustad et al. Jun 2018 B2
10065015 Leeflang et al. Sep 2018 B2
10076639 Guo et al. Sep 2018 B2
10086172 Okamura Oct 2018 B2
20010049499 Lui Dec 2001 A1
20020058910 Hermann et al. May 2002 A1
20020072712 Nool et al. Jun 2002 A1
20030050604 Lui et al. Mar 2003 A1
20030083623 Berg et al. May 2003 A1
20040059296 Godfrey Mar 2004 A1
20040122360 Waldhauser et al. Jun 2004 A1
20040267202 Potter Dec 2004 A1
20040267203 Potter et al. Dec 2004 A1
20050020981 Kurth Jan 2005 A1
20050090779 Osypka Apr 2005 A1
20050090802 Connors et al. Apr 2005 A1
20050149105 Leeflang et al. Jul 2005 A1
20050182387 Webler Aug 2005 A1
20060095050 Hartley et al. May 2006 A1
20060111614 Saadat et al. May 2006 A1
20060135981 Lenker et al. Jun 2006 A1
20060149293 King et al. Jul 2006 A1
20060161135 VanDerWoude Jul 2006 A1
20060200110 Lentz et al. Sep 2006 A1
20060287574 Chin Dec 2006 A1
20070225659 Melsheimer Sep 2007 A1
20080046005 Lenker et al. Feb 2008 A1
20080051734 Bonutti et al. Feb 2008 A1
20080051821 Gephart Feb 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080306442 Bardsley et al. Dec 2008 A1
20090143739 Nardeo et al. Jun 2009 A1
20090240202 Drasler et al. Sep 2009 A1
20090287187 Legaspi Nov 2009 A1
20100082000 Honeck et al. Apr 2010 A1
20100204655 Melsheimer Aug 2010 A1
20100228178 McGraw Sep 2010 A1
20100241083 Fisher et al. Sep 2010 A1
20100268196 Hastings et al. Oct 2010 A1
20100305509 Osypka et al. Dec 2010 A1
20100312190 Searfoss et al. Dec 2010 A1
20110054405 Whiting Mar 2011 A1
20110270196 Valaie Nov 2011 A1
20120245527 Stephens et al. Sep 2012 A1
20120271236 Bruszewski Oct 2012 A1
20130072956 Searfoss et al. Mar 2013 A1
20130131718 Jenson et al. May 2013 A1
20130150793 Beissel Jun 2013 A1
20130310765 Stephens et al. Nov 2013 A1
20130317438 Ellingwood et al. Nov 2013 A1
20130317481 Ellingwood et al. Nov 2013 A1
20150051541 Kanemasa et al. Feb 2015 A1
20150201963 Snow Jul 2015 A1
20150352330 Wasdyke et al. Dec 2015 A1
20160001042 Worley et al. Jan 2016 A1
20160051798 Weber et al. Feb 2016 A1
20160058976 Okamura et al. Mar 2016 A1
20160066948 Ellingwood et al. Mar 2016 A1
20160096000 Mustapha Apr 2016 A1
20160220358 Wilson et al. Aug 2016 A1
20160346507 Jackson et al. Dec 2016 A1
20160346508 Williams et al. Dec 2016 A1
20160354583 Ellingwood et al. Dec 2016 A1
20160375222 Vada Dec 2016 A1
20170043135 Knutsson Feb 2017 A1
20170056063 Ellingwood et al. Mar 2017 A1
20170065267 Fantuzzi Mar 2017 A1
20170072165 Lim et al. Mar 2017 A1
20170113018 Shimizu et al. Apr 2017 A1
20170120008 Burkholz et al. May 2017 A1
20170238965 Murphy Aug 2017 A1
20170252535 Ganske et al. Sep 2017 A1
20170281908 Ellingwood et al. Oct 2017 A1
20170296777 Heisel et al. Oct 2017 A1
20170333682 Nardeo Nov 2017 A1
20170340860 Eberhardt et al. Nov 2017 A1
20180001061 Okamura et al. Jan 2018 A1
20180015254 Cragg et al. Jan 2018 A1
20180043138 Chu Feb 2018 A1
20180056037 Shimizu Mar 2018 A1
20180161540 Fantuzzi Jun 2018 A1
20180250498 Stern et al. Sep 2018 A1
20180256847 Lareau et al. Sep 2018 A1
20180361116 Quick et al. Dec 2018 A1
20190351194 Korkuch Nov 2019 A1
Foreign Referenced Citations (16)
Number Date Country
104174107 Dec 2014 CN
1212185 Jun 2002 EP
1444000 Aug 2004 EP
2335764 Jun 2011 EP
3347079 Jul 2018 EP
4695878 Jun 2011 JP
2011130846 Jul 2011 JP
5581139 Aug 2014 JP
WO-9308986 May 1993 WO
WO-9315872 Aug 1993 WO
WO-9737713 Oct 1997 WO
WO-0048659 Aug 2000 WO
WO-0141858 Jun 2001 WO
WO 2009114556 Sep 2009 WO
WO-2017094697 Jun 2017 WO
WO-2018191547 Oct 2018 WO
Non-Patent Literature Citations (3)
Entry
International Search Rerport for International Patent Application No. PCT/US2018/059486, dated Apr. 30, 2019.
International Preliminary Report on Patentability and Written Opinion for application No. PCT/US2018/059486 dated May 22, 2020.
International Search Report and Written Opinion for International Application No. PCT/US2018/059486 dated Apr. 30, 2019.
Related Publications (1)
Number Date Country
20190134374 A1 May 2019 US
Provisional Applications (1)
Number Date Country
62582075 Nov 2017 US